Session » Pediatric Rheumatology – Clinical Poster II
- 10:30AM-12:30PM
-
Abstract Number: 1280
Abnormal Cortical Gyrification Patterns in Adolescents with Childhood-onset SLE: Early Associations with Perceived Fatigue
- 10:30AM-12:30PM
-
Abstract Number: 1283
Acute Transverse Myelitis in Pediatric Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1259
Adverse Childhood Experiences Are Associated with Patient-Reported Outcomes in Adolescents and Young Adults with Systemic Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1269
Altered Tryptophan Metabolism in Juvenile Dermatomyositis Is Associated with Muscle Damage and Mental Health
- 10:30AM-12:30PM
-
Abstract Number: 1273
An Investigation of Traumatic Events and Mental Health in cSLE
- 10:30AM-12:30PM
-
Abstract Number: 1272
Angiopoietin-2 and Soluble Tumor Necrosis Factor Receptor Type II Are Elevated in Treatment Naïve JDM Plasma and Associate with Increased Muscle Disease Activity and Decreased Nailfold Capillary Density
- 10:30AM-12:30PM
-
Abstract Number: 1266
Anti-Mitochondrial Antibodies Associate with Disease Activity and IFNα Expression in Childhood-onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1267
Antiphospholipid Antibody-related Clinical Manifestations Presenting During Childhood versus Adulthood: Descriptive Results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- 10:30AM-12:30PM
-
Abstract Number: 1265
Approach to Janus Kinase Inhibition for Juvenile Dermatomyositis Among Childhood Arthritis and Rheumatology Research Alliance (CARRA) and Paediatric Rheumatology European Society (PReS) Providers
- 10:30AM-12:30PM
-
Abstract Number: 1263
Assessing Lupus Low Disease Activity State in the Pediatric Rheumatology Clinic: Baseline Data Collection from a Pediatric Lupus Collaborative
- 10:30AM-12:30PM
-
Abstract Number: 1270
Association of Disease-Modifying Anti-Rheumatic Drug Selection with Hospitalized Infection in Youth with Childhood-Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1261
Association of Muscle Biopsies and Functional Recovery Trajectories in Children with Juvenile Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1279
Cerebrovascular Accidents in Pediatric and Adult Systemic Lupus Erythematosus: A Comparison of Epidemiology and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 1274
Comparing Performance-Based Measures and Self-Reported Questionnaires for Assessment of Executive Function for Youth with Childhood-Onset Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1256
Higher Disease Activity in Pediatric Systemic Lupus Erythematosus Is Associated with a Greater Desire for Social Health Education: An Unmet Need in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 1275
Implementing Integrated Mental Health Care in a Juvenile Myositis Clinic: A One-Year Review
- 10:30AM-12:30PM
-
Abstract Number: 1264
Improving Mental Health Care for Youth with Juvenile Dermatomyositis Through Integration of Mental Health Screening into Pediatric Rheumatology Clinic
- 10:30AM-12:30PM
-
Abstract Number: 1258
Investigating Factors Associated with Gaps in Care in Adolescents and Young Adults with Systemic Lupus
- 10:30AM-12:30PM
-
Abstract Number: 1282
Investigating the Genetics of Depression and Anxiety in Children and Adolescents with and Without Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1271
Linkage of the Childhood Arthritis and Rheumatology Research Alliance Registry with the Pediatric Health Information System: Creation of a Comprehensive Childhood-Onset Lupus Dataset
- 10:30AM-12:30PM
-
Abstract Number: 1268
Neutrophil Lymphocyte Ratio as a Novel Marker of Skin Disease Activity in Older Children with Juvenile Dermatomyositis
- 10:30AM-12:30PM
-
Abstract Number: 1281
The Brazilian Registry of Juvenile Dermatomyositis: Relationship Between Ultraviolet Radiation and Laboratory Markers of Juvenile Dermatomyositis in a Tropical Country
- 10:30AM-12:30PM
-
Abstract Number: 1278
The Effects of Fatigue on Self-Reported Mental and Physical Health in Childhood-Onset Systemic Lupus Erythematosus: A Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 1257
The Immune and Growth Characteristics of Children Born to Mothers with Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1285
The Impact of Race and Social Determinants of Health on Patient Reported Outcomes in Pediatric Lupus: A CARRA Registry Study
- 10:30AM-12:30PM
-
Abstract Number: 1262
The Relationship Between Child Opportunity Index and Burden of Pediatric Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1276
Therapeutic Drug Monitoring (TDM) of Rituximab to Predict Early B-Cell Repopulation in Children
- 10:30AM-12:30PM
-
Abstract Number: 1260
Toward a Treat-to-target Strategy in Juvenile Dermatomyositis: Seeking for Suitable Targets and Optimal Timing of Their Achievement
- 10:30AM-12:30PM
-
Abstract Number: 1284
Unlocking Insights into Juvenile Dermatomyositis: Clinical and Demographic Profiles Paired with Total Improvement Scores at a Tertiary Center